Northland Securities analyst Carl Byrnes maintained a Buy rating on Alvotech (ALVO – Research Report) today and set a price target of $28.00.

Alvotech (NASDAQ:ALVO – Get Free Report) is expected to issue its quarterly earnings data after the market closes on ...

Alvotech (ALVO) announced the appointment of Balaji Prasad as chief strategy officer. He was most recently a director and equities analyst at ...

Treatment table ALVO Menuet 4-00 has been designed to support the patient during all surgical procedures and operations: general surgery, vascular surgery, endoscopy, neurosurgery, gynecology and ...

Operating table system ALVO Sonata 4-03 has been designed to support the patient during all surgical procedures and operations: general surgeries, vascular surgeries, endoscopy, neurosurgery ...

Learn more about whether Alvotech or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which ...

Learn more about whether Alvotech or TG Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which ...